SCHEMBL6601874

SCHEMBL6601874

COc1ccc(C2=NN(C(=O)Cc3ccc(NC(=O)c4cccnc4)cc3)CCC2)cc1OC1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.47
▸ ABCB1 P08183 1/20 0.47
▸ PDE4A P27815 8/20 0.46
▸ PDE4B Q07343 7/20 0.46
▸ PDE4D Q08499 7/20 0.46
▸ PDE4C Q08493 6/20 0.46
▸ ALDH1A1 P00352 2/20 0.44
▸ PDE5A O76074 1/20 0.42
▸ PDE1A P54750 1/20 0.42
▸ PDE1B Q01064 1/20 0.42
▸ PDE1C Q14123 1/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ TP53 P04637 1/20 0.40
▸ GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6602147 0.93 PDE5A (0.46) ABCG2ABCB1PDE4APDE4BPDE4D
SCHEMBL6601945 0.93 ABCG2 (0.53) ABCG2ABCB1PDE4BALDH1A1NPC1
Hydrochloric Acid SCHEMBL7650717 0.92 ABCG2 (0.53) ABCG2ABCB1PDE4BALDH1A1NPC1
SCHEMBL145065 0.90 PDE4A (0.51) ABCG2ABCB1PDE4APDE4BPDE4D
SCHEMBL6602631 0.89 ABCG2 (0.48) ABCG2ABCB1PDE4BALDH1A1NPC1
Hydrochloric Acid SCHEMBL7646226 0.89 PDE4D (0.50) ABCG2ABCB1PDE4APDE4BPDE4D
SCHEMBL6272663 0.88 PDE4A (0.48) ABCG2ABCB1PDE4APDE4BPDE4D
SCHEMBL6606959 0.88 ABCG2 (0.47) ABCG2ABCB1PDE4BALDH1A1NPC1
SCHEMBL145758 0.86 PDE5A (0.49) PDE4APDE4BPDE4DPDE4CALDH1A1
SCHEMBL6601996 0.85 ABCG2 (0.48) ABCG2ABCB1PDE4BALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 — — EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 — — US disclosed
EP-1143944-A3 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2002-09-11 — — EP disclosed
EP-1143944-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GmbH (DE) 2001-10-17 — — EP disclosed
WO-2000059484-A2 USE OF ARYLALKANOYLPYRIDAZINES MERCK PATENT GMBH (DE) 2000-10-12 — — WO disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 — — US disclosed
EP-0922036-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GmbH (DE) 1999-06-16 — — EP disclosed
WO-1998006704-A1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 1998-02-19 — — WO disclosed
Send feedback